亞太蛋白質定序市場：按應用、最終用戶和國家進行分析和預測（2024-2033 年）

亞太地區蛋白質定序市場規模預計將從 2024 年的 3.713 億美元成長至 2033 年的 6.235 億美元，預測期內的複合年成長率為 5.93%。

由於對蛋白質體學研究的投資不斷增加、生物製藥行業不斷擴張以及個人化醫療的需求不斷成長，亞太地區對蛋白質定序的採用正在加速。兩種主要的定序技術分別是適用於較小蛋白質的Edman分解技術和因高通量和分析複雜樣本的能力而被廣泛用於大規模蛋白質體學的質譜技術。市場包括支援定序過程的儀器、試劑和消耗品，以及提供專門定序服務的CRO。

對生物標記發現、藥物開發和疾病診斷的需求不斷成長，推動著蛋白質定序技術的不斷創新。隨著亞太地區政府和私營部門對生命科學的大力投資，該地區有望在蛋白質體學和基於蛋白質的研究方面取得重大進展。

受生命科學投資增加、生技產業不斷擴大以及精準醫療需求不斷成長的推動，亞太地區的蛋白質定序市場正在快速成長。隨著中國、日本、印度和韓國等國家加大對蛋白質體學研究的重視，蛋白質定序在藥物發現、疾病診斷和生物標記識別中發揮主導作用。

高解析度質譜和自動Edman分解等定序技術的進步提高了蛋白質分析的準確性和效率。此外，研究機構、製藥公司和委外研發機構（CRO）之間的合作正在促進創新並加速市場擴張。

慢性病發病率的不斷上升以及對標靶治療的需求進一步推動了蛋白質定序在生物醫學研究中的應用。強而有力的政府支持、不斷增加的研發資金和技術進步將顯著擴大亞太地區的蛋白質定序市場，塑造該地區個人化醫療和生物製藥發展的未來。

市場區隔

細分一：按應用

• 生物治療
• 基因工程
• 其他

細分 2：按最終用戶

• 學術機構
• 製藥公司和 CRO
• 生物技術、診斷和其他公司

細分 3：按地區

• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 其他

本報告研究了亞太地區的蛋白質定序市場，並總結了主要趨勢、影響市場的因素分析、法律制度、技術發展和專利趨勢、市場規模趨勢和預測、各個細分市場和主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

執行摘要

第 1 章亞太蛋白質定序市場概述

• 趨勢：當前和未來的影響評估
  • 增加市場上的產品推出
  • 擴大單分子蛋白質定序的應用
  • 生技藥品開發需求旺盛
• 蛋白質定序工作流程
  • 蛋白質定序工作流程概述
• 法律規範
  • 日本
  • 中國
• 專利分析
  • 專利申請趨勢（按國家）
  • 專利申請趨勢（按年份）
• 市場動態概覽
  • 市場促進因素
  • 市場限制
  • 市場機會

2. 亞太地區蛋白質定序市場（依國家）

• 區域摘要
• 亞太地區
  • 區域概況
  • 市場成長推進因素
  • 市場問題
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 其他

第3章市場：競爭格局

• 蛋白質定序市場：競爭格局
  • 企業策略：2021 年 1 月 - 2024 年 9 月
• 業務策略：2021 年 1 月至 2024 年 9 月
  • 服務/產品發布
• 公司簡介
  • FUJIFILM Holdings Corporation
  • Shimadzu Corporation

第4章調查方法

Introduction to Asia-Pacific Protein Sequencing Market

The Asia-Pacific protein sequencing market is projected to reach $623.5 million by 2033 from $371.3 million in 2024, growing at a CAGR of 5.93% during the forecast period 2024-2033. Protein sequencing is the process of identifying the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It is crucial in biotechnology, biomedical research, drug discovery, and disease diagnostics, playing a key role in advancing precision medicine and targeted therapies. Protein sequencing provides critical insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In the APAC region, the adoption of protein sequencing is accelerating, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and rising demand for personalized medicine. The two primary sequencing techniques are Edman degradation, suitable for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market includes instruments, reagents, and consumables that enable sequencing processes, along with contract research organizations offering specialized sequencing services.

Growing demand for biomarker discovery, drug development, and disease diagnostics is fostering continuous innovation in protein sequencing technologies. As governments and private sectors in APAC invest heavily in life sciences, the region is poised for significant advancements in proteomics and protein-based research.

Market Introduction

The APAC protein sequencing market is experiencing rapid growth, driven by increasing investments in life sciences, expanding biotechnology sectors, and the rising demand for precision medicine. As countries like China, Japan, India, and South Korea strengthen their focus on proteomics research, protein sequencing is gaining traction in drug discovery, disease diagnostics, and biomarker identification.

Advancements in sequencing technologies, such as high-resolution mass spectrometry and automated Edman degradation, are enhancing the accuracy and efficiency of protein analysis. Additionally, collaborations between research institutions, pharmaceutical companies, and contract research organizations (CROs) are fostering innovation and accelerating market expansion.

The growing prevalence of chronic diseases and the need for targeted therapies further drive the adoption of protein sequencing in biomedical research. With strong government support, increased R&D funding, and technological advancements, the APAC protein sequencing market is set for significant expansion, shaping the future of personalized medicine and biopharmaceutical development in the region.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Shimadzu Corporation
• FUJIFILM Holdings Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Asia-Pacific Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 Japan
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Japan
  • 1.3.2 China
    • 1.3.2.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Asia-Pacific Protein Sequencing Market (by Country), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 Japan
  • 2.2.6 India
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets - Competitive Landscape

• 3.1 Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
• 3.2 Business Strategies, January 2021-September 2024
  • 3.2.1 Service/Product Launches
• 3.3 Company Profiles
  • 3.3.1 FUJIFILM Holdings Corporation
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Target Customers/End Users
    • 3.3.1.5 Analyst View
  • 3.3.2 Shimadzu Corporation
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Target Customers/End Users
    • 3.3.2.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Protein Sequencing Market, $Million, 2024, 2028, and 2033
• Figure 2: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 3: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 4: Key Events to Keep Track of in the Protein Sequencing Market
• Figure 5: Protein Sequencing Workflow Overview
• Figure 6: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
• Figure 7: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
• Figure 8: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 9: China Protein Sequencing Market, $Million, 2022-2033
• Figure 10: Japan Protein Sequencing Market, $Million, 2022-2033
• Figure 11: India Protein Sequencing Market, $Million, 2022-2033
• Figure 12: Australia Protein Sequencing Market, 2022-2033
• Figure 13: South Korea Protein Sequencing Market, $Million, 2022-2033
• Figure 14: Rest-of-Asia-Pacific Protein Sequencing Market, $Million, 2022-2033
• Figure 15: Corporate Strategies, January 2021- September 2024
• Figure 16: Product Launches (by Company), January 2021-September 2024
• Figure 17: Data Triangulation
• Figure 18: Top-Down and Bottom-Up Approach
• Figure 19: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Protein Sequencing Market Opportunities
• Table 3: Product Launches, January 2023-September 2024
• Table 4: Companies Providing Single-Molecule Protein Sequencing
• Table 5: List of Molecular Targets Identified with Proteomics
• Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
• Table 7: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2022-2033
• Table 8: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2022-2033